UP!

News

Covanta Holding Corporation -0.72% (industrials)

Q reports

Period Date Adjusted Actuals EPS GAAP EPS
Q4 2020 2021-02-18 Future report Set alerts
Q3 2020 2020-10-22 Future report Set alerts
Q2 2020 2020-07-30 -0.10 -0.10
Q1 2020 2020-05-07 -0.24 -0.24
Q4 2019 2020-02-20 0.09 0.09
Q3 2019 2019-10-24 0.10 0.10
Q2 2019 2019-07-25 -0.16 -0.16
Q1 2019 2019-04-25 0.03 0.03
Q4 2018 2019-02-14 0.04 0.07
Q3 2018 2018-10-25 -0.04 -0.21

Ratings

2016-04-29 Downgrade Robert W. Baird Outperform to Neutral $17.00
2016-04-28 Reiterated Rating Imperial Capital Outperform $17.00 to $18.50
2016-03-18 Reiterated Rating Stifel Nicolaus Buy $16.50 to $18.50
2016-02-19 Lower Price Target BB&T Corp. Buy $18.00 to $16.00
2016-02-18 Lower Price Target Imperial Capital Outperform $18.50 to $17.00
2016-02-18 Upgrade Stifel Nicolaus Hold to Buy $16.50
2016-02-18 Lower Price Target Raymond James $19.00 to $18.50
2016-02-18 Lower Price Target Credit Suisse Neutral $17.00 to $16.00
2016-02-18 Lower Price Target Raymond James Financial Inc. $19.00 to $18.50
2016-02-18 Lower Price Target Credit Suisse Group AG Neutral $17.00 to $16.00
2016-02-17 Lower Price Target Robert W. Baird Outperform $18.00 to $17.00
2016-02-16 Lower Price Target Barclays Equal Weight $17.00 to $16.00
2016-02-16 Lower Price Target Barclays PLC Equal Weight $17.00 to $16.00
2016-02-04 Lower Price Target Robert W. Baird Outperform $22.00 to $18.00
2016-01-20 Reiterated Rating Oppenheimer Outperform $21.00 to $20.00
2016-01-20 Reiterated Rating Oppenheimer Holdings Inc. Outperform $21.00 to $20.00
2015-12-30 Reiterated Rating Wedbush Buy
2015-12-29 Lower Price Target Wedbush Outperform $23.00 to $21.00
2015-12-10 Reiterated Rating Imperial Capital Outperform $20.00 to $18.50
2015-12-07 Downgrade Stifel Nicolaus Buy to Hold
2015-12-02 Initiated Coverage Oppenheimer Outperform $21.00
2015-11-19 Lower Price Target Barclays Equal Weight $19.00 to $17.00
2015-11-06 Initiated Coverage Credit Suisse Neutral $18.00
2015-11-02 Lower Price Target BB&T Corp. Buy $20.00
2015-10-29 Lower Price Target Wedbush $25.00 to $23.00
2015-10-29 Lower Price Target Imperial Capital Outperform $24.00 to $20.00
2015-10-25 Reiterated Rating Robert W. Baird Buy
2015-10-23 Lower Price Target Robert W. Baird Outperform $25.00 to $22.00
2015-10-19 Lower Price Target Macquarie Neutral $21.00 to $19.00
2015-10-08 Lower Price Target Wedbush Outperform $27.00 to $25.00
2015-10-01 Reiterated Rating Wedbush Buy $27.00
2015-07-20 Reiterated Rating Robert W. Baird Outperform $25.00
2015-07-09 Reiterated Rating Wedbush Outperform $26.00
2015-05-05 Upgrade Robert W. Baird Neutral to Outperform $23.00 to $25.00
2015-02-13 Initiated Coverage Imperial Capital Buy $24.00
2015-02-12 Lower Price Target Barclays Equal Weight $23.00 to $22.00
2015-01-06 Lower Price Target Barclays Equal Weight $24.00 to $23.00
2014-12-17 Downgrade Robert W. Baird Outperform to Neutral $23.00
2014-12-02 Downgrade Barclays Overweight to Equal Weight $24.00
2014-10-27 Initiated Coverage Macquarie Neutral $26.00 to $23.00
2014-10-24 Reiterated Rating Imperial Capital Outperform $23.50 to $24.00
2014-09-22 Reiterated Stifel Buy $24 to $25
2014-09-22 Boost Price Target Stifel Nicolaus Buy $24.00 to $25.00
2014-07-25 Boost Price Target Ardour Capital Hold $17.00 to $20.00
2014-07-24 Reiterated Rating Raymond James Strong-Buy $23.00 to $25.00
2014-07-24 Upgrade Imperial Capital In-Line to Outperform
2014-06-11 Boost Price Target Imperial Capital In-Line $19.00 to $22.00
2014-06-11 Reiterated Rating Macquarie Outperform $21.00 to $25.00
2014-06-11 Boost Price Target Credit Suisse Neutral $19.00 to $22.00
2014-06-10 Boost Price Target Wunderlich Buy $22.00 to $24.00
2014-06-10 Boost Price Target Barclays Overweight $22.00 to $24.00
2014-05-21 Initiated BB&T Capital Mkts Buy $23
2014-05-21 Initiated Coverage BB&T Corp. Buy $23.00
2014-05-09 Upgrade Barclays Equal Weight to Overweight $20.00 to $22.00
2014-05-05 Upgrade Wedbush Neutral to Outperform $20.00 to $23.00
2014-04-24 Reiterated Rating Barclays Equal Weight $20.00
2014-04-24 Reiterated Rating Imperial Capital In-Line $19.50
2014-04-17 Initiated Coverage Macquarie Outperform $20.00
2014-03-31 Upgrade Raymond James Outperform to Strong-Buy $23.00
2014-03-26 Upgrade Robert W. Baird Neutral to Outperform $18.00 to $21.00
2014-03-03 Upgrade Ned Davis Research Sell to Neutral
2013-11-22 Initiated Coverage Imperial Capital In-Line $19.00
2013-11-05 Lower Price Target Barclays Equal Weight $20.00 to $19.00
2013-10-25 Lower Price Target Wedbush Neutral $23.00 to $21.00
2013-10-25 Downgrade Ascendiant Capital Markets Buy to Neutral
2013-10-22 Lower Price Target Barclays Equal Weight $21.00 to $20.00
2013-10-17 Initiated Coverage Stifel Nicolaus Hold
2013-10-17 Downgrade Wedbush Outperform to Neutral $24.00 to $23.00
2013-10-14 Downgrade Raymond James Strong-Buy to Outperform $24.00 to $23.00
2013-02-08 Downgrade Ardour Capital Accumulate to Hold $21
2013-01-09 Downgrade Robert W. Baird Outperform to Neutral $20
2012-12-27 Initiated Capstone Investments Buy $23
2012-10-18 Downgrade Ardour Capital Buy to Accumulate $21 to $21
2012-03-13 Initiated KeyBanc Capital Mkts Buy $20
2012-03-06 Upgrade Barclays Capital Equal Weight to Overweight $18 to $20
2011-10-21 Upgrade Ardour Capital Accumulate to Buy $21
2009-10-16 Downgrade Oppenheimer Outperform to Perform
2016-04-29 Downgrade Robert W. Baird Outperform to Neutral $17.00
2016-04-28 Reiterated Rating Imperial Capital Outperform $17.00 to $18.50
2016-03-18 Reiterated Rating Stifel Nicolaus Buy $16.50 to $18.50
2016-02-19 Lower Price Target BB&T Corp. Buy $18.00 to $16.00
2016-02-18 Lower Price Target Imperial Capital Outperform $18.50 to $17.00

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
SZ INVESTMENTS LLC 1.55%  (2027500) CVA /
PATE WILLIAM 0.31%  (407177) CVA / EXH /
Jones Stephen J President and CEO 0.17%  (226057) APD / CVA /
ZELL SAMUEL 0.11%  (137663) AXE / BXMT / CVA / CWH / ELS / EQR /
ORLANDO ANTHONY J President and CEO 0.10%  (135067) CVA / LSTR /
Simpson Timothy Exec. VP, Gen\'l Counsel & Sec. 0.10%  (131501) CVA /
Veenhof Derek Executive VP - Waste Solutions 0.09%  (122936) CVA /
HOLSTEN JOSEPH M 0.08%  (102538) CVA / LKQ /
SMITH JEAN 0.08%  (101784) CVA /
SILBERMAN ROBERT S 0.08%  (100000) CVA / FOXA / STRA /
Barse David Michael 0.08%  (98960) CVA /
Khattri Sanjiv Executive VP & CFO 0.07%  (93834) CVA / PAH /
Mulcahy Matthew SVP & Head of Corp Development 0.06%  (81563) CVA /
BYNOE PETER C B 0.06%  (75122) CVA / FTR / RELY /
Helgeson Bradford J Executive VP & CFO 0.06%  (72941) CVA /
Klett John EVP & Chief Operating Officer 0.06%  (72849) CVA /
de Castro Michael Joseph EVP Supply Chain 0.05%  (68008) CVA /
Myones Seth Pres. Americas Covanta Energy 0.05%  (63988) CVA /
Wright Michael A. SVP and Chief HR Officer 0.04%  (57268) CVA /
Fisher Linda J. 0.04%  (46736) CVA /
Stauder Paul E. President, Covanta Envir. Sol. 0.04%  (46347) CVA /
BUCKS THOMAS VP and Chief Acctg Officer 0.03%  (44335) CVA /
RANGER MICHAEL W 0.03%  (40000) CVA / ED /
Zieselman Neil VP & Chief Accounting Officer 0.01%  (15910) CVA /
Broglio Ronald J 0.01%  (15251) CVA /
Grewal Manpreet VP & Chief Accounting Officer 0.01%  (14925) CVA /

Comments